0000950123-21-011532.txt : 20210816 0000950123-21-011532.hdr.sgml : 20210816 20210816162659 ACCESSION NUMBER: 0000950123-21-011532 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 EFFECTIVENESS DATE: 20210816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SV Health Investors, LLC CENTRAL INDEX KEY: 0001587143 IRS NUMBER: 861154144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16271 FILM NUMBER: 211178739 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: SV Life Sciences Advisers, LLC DATE OF NAME CHANGE: 20130918 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001587143 XXXXXXXX 06-30-2021 06-30-2021 false SV Health Investors, LLC

ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108

13F HOLDINGS REPORT 028-16271 Y The filing of this report shall not be deemed an admission, for purposes of Section 13(t), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Health Investors, LLC, a Delaware limited liability company ("Investors"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), and SV Life Sciences Fund VI, L.P. ("SVLS VI LP") and SV Life Sciences Fund VI Strategic Partners, L.P. ("Strategic Partners VI" and together with SVLS VI LP, the "Fund VI Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund V Entities and the Fund VI Entities together, the "Funds"), directly own certain security positions reported by Investors, which is the investment adviser of the Funds. SV Life Sciences Fund VI (GP), L.P., a Delaware limited partnership ("SVLS VI GP") is the general partner of the Fund VI Entities, and SVLSF VI, LLC, a Delaware limited liability company is the general partner of SVLS VI GP. Certain of the security positions reported by Investors are also being reported by SVLS VI GP and SVLSF VI, LLC (together, the "GPs"). Each of SVLS VI GP, SVLSF VI, LLC and Investors may be deemed to share voting power and control over the shares held by the Fund VI Entities. Investors may also be deemed to share voting power and control over the shares held by the Fund IV and Fund V Entities. Each of the GPs and Investors disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein. Brent M. Faduski (617) 367-8100 /s/ Brent M. Faduski Boston MA 08-16-2021 2 7 229564 false 1 028-19256 SVLSF VI, LLC 2 028-19255 SV Life Sciences Fund VI (GP), L.P. INFORMATION TABLE 2 5794.xml INFORMATION TABLE FOR FORM 13F ASENSUS SURGICAL, INC. COM NEW 04367G103 1618 510142 SH OTR 0 510142 0 DECIPHERA PHARMACEUTICALS INC COM 24344T101 16473 449951 SH OTR 1,2 0 449951 0 X4 PHARMACEUTICALS INC COM 98420X103 2025 311490 SH OTR 1,2 0 311490 0 SUTRO BIOPHARMA INC COM 869367102 33918 1824542 SH OTR 0 1824542 0 BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 58147 1915274 SH OTR 1,2 0 1915274 0 MISONIX, INC. COM 604871103 37574 1694017 SH OTR 1,2 0 1694017 0 ADAPTHEALTH CORP. COM 00653Q102 79809 2911677 SH OTR 1,2 0 2911677 0